Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nitric oxide and nitrovasodilators: similarities, differences, and interactions

R A Kelly1, T W Smith

  • 1Cardiovasuclar Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.

The American Journal of Cardiology
|May 30, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting physiologically-relevant oxygen concentrations in precision-cut liver slices using mathematical modelling.

PloS one·2022
Same author

Cytokines and cardiac hypertrophy: roles of angiotensin II and basic fibroblast growth factor.

Clinical and experimental pharmacology & physiology·2010
Same author

Gene therapy progress and prospects: therapeutic angiogenesis for ischemic cardiovascular disease.

Gene therapy·2007
Same author

In vivo electrophysiologic studies in endothelial nitric oxide synthase (eNOS)-deficient mice.

Journal of cardiovascular electrophysiology·2002
Same author

Nitric oxide and cardiac contractility in human heart failure: time for reappraisal.

Circulation·2001
Same author

Activation of cardiac c-Jun NH(2)-terminal kinases and p38-mitogen-activated protein kinases with abrupt changes in hemodynamic load.

Hypertension (Dallas, Tex. : 1979)·2001

Nitric oxide (NO), produced endogenously or exogenously, relaxes vascular smooth muscle. Coronary artery disease impairs NO production, but nitrates still dilate vessels, suggesting therapeutic potential.

Area of Science:

  • Cardiovascular Physiology
  • Endothelial Function
  • Nitric Oxide Biology

Background:

  • The endothelium acts as a semipermeable barrier and secretes vasoactive substances.
  • Endothelium-derived relaxing factor (EDRF) is nitric oxide (NO), crucial for vascular smooth muscle relaxation.
  • NO signaling involves soluble guanylate cyclase and cyclic guanosine monophosphate (cGMP).

Purpose of the Study:

  • To review the dual sources of nitric oxide (endogenous and exogenous) and their mechanisms.
  • To discuss the impact of coronary artery disease on nitric oxide production.
  • To explore the role of the nitric oxide pathway in cardiac autonomic responsiveness.

Main Methods:

  • Review of existing literature on endothelial function and nitric oxide.

Related Experiment Videos

  • Discussion of endogenous nitric oxide synthesis via nitric oxide synthases.
  • Analysis of exogenous nitric oxide administration via organic nitrates.

    • Main Results:

    • Nitric oxide is synthesized endogenously or administered exogenously via nitrates.
    • Coronary artery disease disrupts endogenous nitric oxide production.
    • Exogenous nitrates remain effective vasodilators even with impaired endogenous NO production.

    Conclusions:

    • The nitric oxide pathway is vital for vascular tone and cardiac function.
    • Therapeutic strategies involving nitric oxide are important for cardiovascular health.
    • Further research is needed on nitric oxide's role in cardiac autonomic control and disease states.